MISSION

A future beyond age-related disease.

We build AI-designed peptide therapeutics and vaccines for cancer and aging. Our goal is more years of health, function, and independence. AI ranks mechanisms. The lab validates them. We start with oncology and expand as evidence matures.

Who we are

Cancer, neurodegeneration, cardiovascular disease, and metabolic dysfunction share upstream mechanisms. Agemica organizes around healthspan - preserved function and independence - not vanity charts.

“Aging is the highest-leverage disease driver we can address systematically.”

Operating beliefs

01
Evidence & replication

Programs are judged by mechanism-level evidence and whether results replicate beyond a single assay. Hypotheses are ranked before capital commits-experiments exist to collapse uncertainty.
02
Endpoints & oncology

Endpoints tie to function and resilience where possible; surrogates only when clearly justified. The near-term emphasis is cancer because regulatory and clinical paths still move indication by indication.
03
Claims & platform

Stage-appropriate claims only-preclinical work stays labeled as such until gates are met. The same platform stack applies as datasets widen.

How we work

Science, execution, and boundaries.

01 / 03

Discovery

Computational layers propose candidates and prioritize mechanisms; biological systems decide what survives. Breadth of evidence matters as much as a single headline number.